drugset / Trial / NCT05983445
Safety & Efffficacy of Genakumab in Patients With Frequent Flares
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of Genakumab Injection in patients with Gouty Arthritis (GA).
Timeline
- Start
- 2023-01-11
- Primary completion
- 2024-04-03
- Completion
- 2024-04-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Genakumab | Monoclonal antibody | 200 mg | Subcutaneous |
| Comparator | betamethasone dipropionate | Small molecule | 7 mg | Intramuscular |